Ionis Pharmaceuticals | IONS - Net Income


Ionis Pharmaceuticals reported $-114.65M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Agios Pharmaceuticals USD -99.11M 8.93M Mar/2026
Alnylam Pharmaceuticals USD 164.49M 41.5M Jun/2026
Arrowhead Research USD -194.28M 61.55M Jun/2026
Astellas Pharma JPY 141.83B 98.31B Jun/2026
BioCryst Pharmaceuticals USD 78.4M 167.45M Jun/2026
BioMarin Pharmaceutical USD 44.76M 60.76M Jun/2026
Celltrion KRW 8.82B 64.74M Mar/2026
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Divis Laboratories Ltd INR 9.02B 1.51B Jun/2026
Exelixis USD 212.05M 1.58M Jun/2026
Halozyme Therapeutics USD 229.91M 79.86M Jun/2026
Ionis Pharmaceuticals USD -114.65M 21.65M Jun/2026
Kangmei Pharma CNY -16.56M 12.74M Mar/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -226K 121K Dec/2025
Moderna USD -1.34B 517M Mar/2026
Nektar Therapeutics USD -44.9M 8.82M Mar/2026
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Neurocrine Biosciences USD 144.4M 53.5M Jun/2026
Novartis USD 3.26B 108M Jun/2026
Omeros USD -32.23M 23.81M Sep/2024
OPKO Health USD -54.85M 23.59M Mar/2026
Organigram Holdings CAD -921K 20.89M Mar/2026
Ovoca Bio EUR 4.42M 5.19M Dec/2025
Pfizer USD -248M 2.94B Jun/2026
Pharma Mar EUR -972K 2.5M Jun/2026
PTC Therapeutics USD -2.81M 132.16M Mar/2026
Qiagen NV USD 103.4M 35.36M Jun/2026
Regeneron Pharmaceuticals USD 1.3B 569.7M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Sarepta Therapeutics USD 330.96M 743.18M Mar/2026
Sartorius EUR 65.9M 9.7M Jun/2026
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Tilray USD -44.93M 44.61M Sep/2025
Ultragenyx Pharmaceutical USD -185M 56M Mar/2026
Vertex Pharmaceuticals USD 1.1B 68.4M Jun/2026
Zealand Pharma A/S -394M 14.88M Mar/2026
Zz Pientze Pharmaceu CNY 349.49M 393.99M Jun/2026